Potential biomarkers evaluating cardiac involvement and disease severity, such as C-reactive protein (CRP), IL-6, calprotectin, and dickkopf-related protein 1 (DKK-1), can be assessed in pSS patients [273]. This evidence concerns the gene CRP and peeling skin syndrome.